Second-generation trabecular meshwork bypass stent (istent inject) increases outflow facility in cultured human anterior segments

Cindy K. Bahler, Cheryl R. Hann, Todd Fjield, David Haffner, Hal Heitzmann, Michael P Fautsch

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Purpose: To determine whether a second-generation trabecular meshwork (TM) bypass stent (iStent inject) influences outflow facility in cultured human anterior segments. Design: Prospective laboratory investigation using normal human donor eyes. Methods: Human anterior segments (n = 7) were placed in perfusion organ culture. One or 2 iStent inject stents were inserted into the TM within the nasal and/or superior quadrants using a specially designed injector. Anterior segments were returned to culture and perfused for an additional 24 hours. Morphology of the TM and Schlemm canal (SC) was assessed by scanning electron microscopy (SEM) and 3-dimensional micro-computed tomography (3D micro-CT). Results: Insertion of 1 iStent inject into the nasal or superior quadrant of the TM increased outflow facility from 0.16 ± 0.05 μL/min/mm Hg to 0.38 ± 0.23 μL/min/mm Hg (P <.03, n = 7), with concurrent pressure reduction from 16.7 ± 5.4 mm Hg to 8.6 ± 4.4 mm Hg. Addition of a second iStent inject further increased outflow facility to 0.78 ± 0.66 μL/min/mm Hg (n = 2). SEM showed the iStent inject flange compressed against the uveal region of the TM, the thorax securely inserted within the TM, and the head located in the lumen of SC. Dilation of SC was noted around the iStent inject head and SC cell disruption was observed at the iStent inject insertion site. 3D micro-CT confirmed iStent inject placement. Conclusion: iStent inject, a second-generation bypass stent, increased outflow facility in human anterior segment culture. The iStent inject is a promising new device to lower intraocular pressure via TM bypass.

Original languageEnglish (US)
Pages (from-to)1206-1213
Number of pages8
JournalAmerican Journal of Ophthalmology
Volume153
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Trabecular Meshwork
Stents
Nose
Electron Scanning Microscopy
Head
Tomography
Organ Culture Techniques
Intraocular Pressure
Dilatation
Thorax
Perfusion
Pressure
Equipment and Supplies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Second-generation trabecular meshwork bypass stent (istent inject) increases outflow facility in cultured human anterior segments. / Bahler, Cindy K.; Hann, Cheryl R.; Fjield, Todd; Haffner, David; Heitzmann, Hal; Fautsch, Michael P.

In: American Journal of Ophthalmology, Vol. 153, No. 6, 06.2012, p. 1206-1213.

Research output: Contribution to journalArticle

Bahler, Cindy K. ; Hann, Cheryl R. ; Fjield, Todd ; Haffner, David ; Heitzmann, Hal ; Fautsch, Michael P. / Second-generation trabecular meshwork bypass stent (istent inject) increases outflow facility in cultured human anterior segments. In: American Journal of Ophthalmology. 2012 ; Vol. 153, No. 6. pp. 1206-1213.
@article{967cbcdd716046d3953110e813c5fe7a,
title = "Second-generation trabecular meshwork bypass stent (istent inject) increases outflow facility in cultured human anterior segments",
abstract = "Purpose: To determine whether a second-generation trabecular meshwork (TM) bypass stent (iStent inject) influences outflow facility in cultured human anterior segments. Design: Prospective laboratory investigation using normal human donor eyes. Methods: Human anterior segments (n = 7) were placed in perfusion organ culture. One or 2 iStent inject stents were inserted into the TM within the nasal and/or superior quadrants using a specially designed injector. Anterior segments were returned to culture and perfused for an additional 24 hours. Morphology of the TM and Schlemm canal (SC) was assessed by scanning electron microscopy (SEM) and 3-dimensional micro-computed tomography (3D micro-CT). Results: Insertion of 1 iStent inject into the nasal or superior quadrant of the TM increased outflow facility from 0.16 ± 0.05 μL/min/mm Hg to 0.38 ± 0.23 μL/min/mm Hg (P <.03, n = 7), with concurrent pressure reduction from 16.7 ± 5.4 mm Hg to 8.6 ± 4.4 mm Hg. Addition of a second iStent inject further increased outflow facility to 0.78 ± 0.66 μL/min/mm Hg (n = 2). SEM showed the iStent inject flange compressed against the uveal region of the TM, the thorax securely inserted within the TM, and the head located in the lumen of SC. Dilation of SC was noted around the iStent inject head and SC cell disruption was observed at the iStent inject insertion site. 3D micro-CT confirmed iStent inject placement. Conclusion: iStent inject, a second-generation bypass stent, increased outflow facility in human anterior segment culture. The iStent inject is a promising new device to lower intraocular pressure via TM bypass.",
author = "Bahler, {Cindy K.} and Hann, {Cheryl R.} and Todd Fjield and David Haffner and Hal Heitzmann and Fautsch, {Michael P}",
year = "2012",
month = "6",
doi = "10.1016/j.ajo.2011.12.017",
language = "English (US)",
volume = "153",
pages = "1206--1213",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Second-generation trabecular meshwork bypass stent (istent inject) increases outflow facility in cultured human anterior segments

AU - Bahler, Cindy K.

AU - Hann, Cheryl R.

AU - Fjield, Todd

AU - Haffner, David

AU - Heitzmann, Hal

AU - Fautsch, Michael P

PY - 2012/6

Y1 - 2012/6

N2 - Purpose: To determine whether a second-generation trabecular meshwork (TM) bypass stent (iStent inject) influences outflow facility in cultured human anterior segments. Design: Prospective laboratory investigation using normal human donor eyes. Methods: Human anterior segments (n = 7) were placed in perfusion organ culture. One or 2 iStent inject stents were inserted into the TM within the nasal and/or superior quadrants using a specially designed injector. Anterior segments were returned to culture and perfused for an additional 24 hours. Morphology of the TM and Schlemm canal (SC) was assessed by scanning electron microscopy (SEM) and 3-dimensional micro-computed tomography (3D micro-CT). Results: Insertion of 1 iStent inject into the nasal or superior quadrant of the TM increased outflow facility from 0.16 ± 0.05 μL/min/mm Hg to 0.38 ± 0.23 μL/min/mm Hg (P <.03, n = 7), with concurrent pressure reduction from 16.7 ± 5.4 mm Hg to 8.6 ± 4.4 mm Hg. Addition of a second iStent inject further increased outflow facility to 0.78 ± 0.66 μL/min/mm Hg (n = 2). SEM showed the iStent inject flange compressed against the uveal region of the TM, the thorax securely inserted within the TM, and the head located in the lumen of SC. Dilation of SC was noted around the iStent inject head and SC cell disruption was observed at the iStent inject insertion site. 3D micro-CT confirmed iStent inject placement. Conclusion: iStent inject, a second-generation bypass stent, increased outflow facility in human anterior segment culture. The iStent inject is a promising new device to lower intraocular pressure via TM bypass.

AB - Purpose: To determine whether a second-generation trabecular meshwork (TM) bypass stent (iStent inject) influences outflow facility in cultured human anterior segments. Design: Prospective laboratory investigation using normal human donor eyes. Methods: Human anterior segments (n = 7) were placed in perfusion organ culture. One or 2 iStent inject stents were inserted into the TM within the nasal and/or superior quadrants using a specially designed injector. Anterior segments were returned to culture and perfused for an additional 24 hours. Morphology of the TM and Schlemm canal (SC) was assessed by scanning electron microscopy (SEM) and 3-dimensional micro-computed tomography (3D micro-CT). Results: Insertion of 1 iStent inject into the nasal or superior quadrant of the TM increased outflow facility from 0.16 ± 0.05 μL/min/mm Hg to 0.38 ± 0.23 μL/min/mm Hg (P <.03, n = 7), with concurrent pressure reduction from 16.7 ± 5.4 mm Hg to 8.6 ± 4.4 mm Hg. Addition of a second iStent inject further increased outflow facility to 0.78 ± 0.66 μL/min/mm Hg (n = 2). SEM showed the iStent inject flange compressed against the uveal region of the TM, the thorax securely inserted within the TM, and the head located in the lumen of SC. Dilation of SC was noted around the iStent inject head and SC cell disruption was observed at the iStent inject insertion site. 3D micro-CT confirmed iStent inject placement. Conclusion: iStent inject, a second-generation bypass stent, increased outflow facility in human anterior segment culture. The iStent inject is a promising new device to lower intraocular pressure via TM bypass.

UR - http://www.scopus.com/inward/record.url?scp=84861194914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861194914&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2011.12.017

DO - 10.1016/j.ajo.2011.12.017

M3 - Article

VL - 153

SP - 1206

EP - 1213

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 6

ER -